WuXi PharmaTech (WX) Tops Q2 EPS by 1c

WuXi PharmaTech (NYSE: WX) reported Q2 EPS of $0.33, $0.01 better than the analyst estimate of $0.32. Revenue for the quarter came in at $130.4 million versus the consensus estimate of $126.65 million.

For earnings history and earnings-related data on WuXi PharmaTech (WX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
• Benchmark Reiterates Buy Rating on Jumia Technologies (JMIA)